Shravan Chintapatla

Shravan Chintapatla

Active Director Director DIN 02698825
DIN 02698825 First appointment Oct 2009 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Oct 2009
Shareholding value •••• Premium profile

About Shravan Chintapatla

Data last updated:

Shravan Chintapatla is a Director at Smartdocs Business Solutions Private Limited (since 2009), Director at Cebis India Limited (since 2020) and Director at Vanta Clinical Research Limited (since 2020), and holds 1 more current directorship. The companies operate in Information Technology, Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹14.27 Cr; the largest is Smartdocs Business Solutions Private Limited at ₹13.05 Cr (FY 2023). Earlier, Shravan Chintapatla was a Director at Sarvotham Remedies Limited (2024–2026).

DIN 02698825
Primary Designation Director
Industry Information Technology
First Appointment 07 Oct 2009
Oldest Company Age 17 yrs
Largest company Smartdocs Business Solutions Private Limited · ₹13.05 Cr (FY 2023)
Combined revenue ₹14.27 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Oct 20092009₹13.05 Cr (FY 2023)Active
Cebis India Limited U73100TG2018PLC127550
Director18 Aug 20202018₹1.22 Cr (FY 2024)Active
Vanta Clinical Research Limited U73100TG2018PLC126673
Director18 Aug 20202018₹1,983 (FY 2021)Active
Metatrade Network Private Limited U72200TG2022PTC166746
Managing Director16 Sep 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sarvotham Remedies Limited U24239TG2002PLC038573
Director10 Sep 20242002₹1.69 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Metatrade Network Private Limited
Vanta Clinical Research Limited
Cebis India Limited
Smartdocs Business Solutions Private Limited
Premium access

Shareholding and investment profile for Shravan Chintapatla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shravan Chintapatla

Shravan Chintapatla currently holds 4 directorships: Smartdocs Business Solutions Private Limited (Director, since 07 Oct 2009, revenue ₹13.05 Cr (FY 2023)); Cebis India Limited (Director, since 18 Aug 2020, revenue ₹1.22 Cr (FY 2024)); Vanta Clinical Research Limited (Director, since 18 Aug 2020, revenue ₹1,983 (FY 2021)); Metatrade Network Private Limited (Managing Director, since 16 Sep 2022).

Shravan Chintapatla was first appointed on 07 Oct 2009 as Director at Smartdocs Business Solutions Private Limited. The most recent appointment on record is 10 Sep 2024 at Sarvotham Remedies Limited.

The 3 current companies of Shravan Chintapatla that report revenue have a combined latest revenue of ₹14.27 Cr: Smartdocs Business Solutions Private Limited ₹13.05 Cr (FY 2023); Cebis India Limited ₹1.22 Cr (FY 2024); Vanta Clinical Research Limited ₹1,983 (FY 2021).

Shravan Chintapatla held 1 earlier board appointment: Sarvotham Remedies Limited (Director, 10 Sep 2024 to 03 Jan 2026).

The current boards of Shravan Chintapatla's companies include Ravindra Kumar Baloda (Smartdocs Business Solutions Private Limited), Umamalleswara Chintapatla Rao (Smartdocs Business Solutions Private Limited), Dopesh Raja Mulakala (Cebis India Limited), Mulakala Sajan Kiran (Cebis India Limited), Yati Brijmohan Chugh (Cebis India Limited), Yati Brijmohan Chugh (Cebis India Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available